PT Millennium Pharmacon International Tbk
Jakarta Stock Exchange SDPC.JK
PT Millennium Pharmacon International Tbk EBITDA for the year ending December 31, 2023: USD 8.09 M
-
PT Millennium Pharmacon International Tbk EBITDA for the year ending December 31, 2022 was USD 5.85 M, a 13.63% change year over year.
-
PT Millennium Pharmacon International Tbk EBITDA for the year ending December 31, 2021 was USD 5.15 M, a 7.70% change year over year.
-
PT Millennium Pharmacon International Tbk EBITDA for the year ending December 31, 2020 was USD 4.78 M, a -5.71% change year over year.
-
PT Millennium Pharmacon International Tbk EBITDA for the year ending December 31, 2019 was USD 5.07 M, a 8.17% change year over year.
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
| CEO | Mr. Ahmad Bin Abu Bakar |
| IPO Date | Sept. 3, 2001 |
| Location | Indonesia |
| Headquarters | Crown Bungur Arteri |
| Employees | 1,172 |
| Sector | Health Care |
| Industries | |
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, dietary supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2021, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Past 5 years
USD 0.05
USD 0.01
USD 0.38
USD 0.01
StockViz Staff
January 15, 2025
Any question? Send us an email